Razieh Avan
Board certified Clinical Pharmacist, Pharmaceutical Research Center, Mazandaran University of Medical Sciences, Sari, Iran Second Affiliation: Clinical Pharmacy Department, Birjand University of Medical Sciences, Birjand, Iran.
[ 1 ] - Comparison of the incidence and severity of side effects profile of FOLFOX and DCF regimens in gastric cancer patients
Abstract Introduction: Gastric cancer is the fourth common cancer and the second leading cause of cancer death worldwide. Due to lack of adequate information on the side effects of chemotherapy regimens in treatment of gastric cancer, this study was aimed to determine the side effects of two common chemotherapy regimens of gastric cancer. Methods: This prospective study was conducte...
[ 2 ] - Comparison of the incidence and severity of side effects profile of FOLFOX and DCF regimens in gastric cancer patients
Abstract Introduction: Gastric cancer is the fourth common cancer and the second leading cause of cancer death worldwide. Due to lack of adequate information on the side effects of chemotherapy regimens in treatment of gastric cancer, this study was aimed to determine the side effects of two common chemotherapy regimens of gastric cancer. Methods: This prospective study was conducte...
[ 3 ] - Evaluation of rational prescription pattern of intravenous immunoglobulin (IVIG) based on FDA-approved indications among teaching hospitals in Birjand
Background and Aims: Intravenous immunoglobulin (IVIG) is one of the safest biological products, which is effective in the treatment of many diseases. This study aimed to evaluate the rational prescription pattern of IVIG based on the approved indications of the Food and Drug Administration (FDA) among teaching hospitals in Birjand, Iran. Materials and Methods: This descriptive-analytical stud...
نویسندگان همکار